51成人动漫

ASCO Breast: Even 'Tweens Fear Breast Cancer

SAN FRANCISCO -- Fear about breast cancer starts early, as girls see it affect those close to them and hear reports in the media, researchers found.

Oct 12, 2009

ASCO: Bevacizumab (Avastin) May Reduce Progression in Advanced Breast Cancer

CHICAGO -- In recurrent or metastatic breast cancer, bevacizumab (Avastin) significantly improved progression-free survival when added to docetaxel (Taxotere), a multicenter European study showed.

Jun 02, 2008

SABCS: Testosterone Relieves Atrophic Vaginitis in Breast Cancer Patients

SAN ANTONIO -- Intravaginal testosterone may offer relief from atrophic vaginitis without the risks of estrogen to breast cancer patients taking aromatase inhibitors, according to a pilot study.

Dec 17, 2007

ASPS: Obese Women Have More Breast Reconstruction Complications

SAN FRANCISCO -- Breast reconstruction surgery in extremely obese women is associated with a high rate of complications, reported researchers here.

Oct 19, 2006

ASCO: Five Years of Arimidex Causes Bone Loss

ATLANTA 芒鈧�鈥� Five years of breast cancer adjuvant therapy with an aromatase inhibitor, can lead to a 6% to 7% loss of bone mineral density, a trigger for osteoporosis for women who are borderline osteopenic when they begin treatment, investigators reported here.

Jun 04, 2006

Estrogen Alone Does Not Increase Risk of Breast Cancer

STANFORD, Calif. - Post-menopausal women who took estrogen alone for more than seven years did not have an increased risk of breast cancer, according to a study of more than 10,000 women ages 50 to 79. The data were dramatically different from a sister study stopped in 2002 of estrogen plus progestin.

Apr 11, 2006